Health Care & Life Sciences » Pharmaceuticals | Rui Kang Pharmaceutical Group Investments Ltd.

Rui Kang Pharmaceutical Group Investments Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2012
2014
2015
2016
2017
2018
Sales/Revenue
61,267.00
70,110.00
34,127.00
86,565.00
105,135.00
70,304
Cost of Goods Sold (COGS) incl. D&A
22,839.00
44,219.00
24,497.00
59,830.00
74,933.00
42,220
Gross Income
38,428.00
25,891.00
9,630.00
26,735.00
30,202.00
28,084
SG&A Expense
48,161.00
47,117.00
43,691.00
69,221.00
71,483.00
99,678
EBIT
-
-
34,061.00
41,824.00
41,281.00
71,594
Unusual Expense
4,105.00
46,677.00
17,852.00
62,677.00
49,283.00
469
Non Operating Income/Expense
1,979.00
5,175.00
600.00
6,441.00
10,569.00
6,731
Interest Expense
2,989.00
1,575.00
402.00
2,010.00
2,189.00
3,472
Pretax Income
14,781.00
74,398.00
60,040.00
95,139.00
75,398.00
69,244
Income Tax
86.00
473.00
389.00
479.00
1,132.00
189
Consolidated Net Income
14,867.00
74,871.00
59,651.00
95,618.00
76,530.00
69,433
Net Income
14,867.00
74,854.00
54,160.00
85,677.00
63,022.00
64,250
Net Income After Extraordinaries
6,956.00
66,779.00
46,051.00
121,203.00
63,022.00
64,250
Net Income Available to Common
22,778.00
82,929.00
62,269.00
84,381.00
63,022.00
64,250
EPS (Basic)
4.66
7.66
0.42
0.07
0.08
0.07
Basic Shares Outstanding
4,904.80
10,816.90
147,035.00
706,883.00
801,222.00
881,719
EPS (Diluted)
4.64
7.67
0.42
0.07
0.08
0.07
Diluted Shares Outstanding
4,904.80
10,816.90
147,035.00
706,883.00
801,222.00
881,719
EBITDA
8,131.00
20,276.00
29,997.00
34,955.00
34,242.00
63,348
Other Operating Expense
-
-
-
662.00
-
-
Non-Operating Interest Income
67.00
172.00
265.00
326.00
144.00
20
Minority Interest Expense
-
17.00
5,491.00
9,941.00
13,508.00
5,183
Equity in Affiliates (Pretax)
-
83.00
7,390.00
4,605.00
6,642.00
460

About Rui Kang Pharmaceutical Group Investments

View Profile
Address
Suites 1904-05A, 19/F, Sino Plaza
Hong Kong
Hong Kong
Employees -
Website http://www.cbshhk.com
Updated 07/08/2019
China Biotech Services Holdings Ltd. is an investment company, which engages in the provision of medical laboratory testing, and health check services. It operates through the following segments: Pharmaceutical Products, Medical and Health Related Services, Securities, and Others. The Pharmaceutical Products segment manufactures, researches, develops, sells, and distributes health related and pharmaceutical products.